Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression - Concepedia

Concepedia

Publication | Closed Access

Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

67

Citations

46

References

2003

Year

Derek L. Stirewalt, F R Appelbaum, Cheryl L. Willman, Richard A. Zager, Deborah E. Banker

Leukemia Research

InflammationCardiovascular DiseaseMedicinePharmacotherapyStatin EfficacyPrimary AmlsPharmacologyTherapeutic Agents

References

	Year	Citations

Page 1